HIGH-RISK ACUTE MYELOID LEUKEMIA
Clinical trials for HIGH-RISK ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for HIGH-RISK ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell boost may keep leukemia at bay after transplant
Disease control Recruiting nowThis study tests whether giving special immune cells (γδ T cells) after a stem cell transplant can help prevent high-risk acute myeloid leukemia from returning. About 40 adults aged 18 to 65 will receive these cells and be monitored for relapse-free survival. The goal is to see i…
Matched conditions: HIGH-RISK ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Immune cell boost may shield kids from Post-Transplant infections
Disease control Recruiting nowThis study tests whether adding a special type of immune cell (memory T cells) after a donor stem cell transplant can help prevent serious viral and fungal infections. It involves up to 100 children and young adults with blood cancers or immune disorders. The approach aims to spe…
Matched conditions: HIGH-RISK ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug combo aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis study tests whether adding venetoclax to the standard chemotherapy before a stem cell transplant can help prevent cancer from returning in people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). About 138 participants aged 12 to 60 will be rand…
Matched conditions: HIGH-RISK ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New app aims to boost quality of life for leukemia patients
Symptom relief Recruiting nowThis study tests a digital app called DREAMLAND to see if it can improve quality of life and emotional well-being for adults with acute myeloid leukemia (AML) who are receiving intensive chemotherapy. About 200 participants will use either DREAMLAND or a standard wellness app. Th…
Matched conditions: HIGH-RISK ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC